|
|
|
| 1 |
8,389,501 |
Anticancer compound
|
| 2 |
8,343,935 |
Wound and skin care products
|
| 3 |
8,329,678 |
Antiinflammatory compound
|
| 4 |
8,211,876 |
Compositions for treatment of inflammatory diseases
|
| 5 |
8,119,618 |
Compositions and methods for the treatment of inflammatory diseases
|
| 6 |
7,928,092 |
Formulations and methods of treating inflammatory bowel disease
|
| 7 |
7,825,106 |
Modified release formulations and methods of treating inflammatory bowel
disease
|
| 8 |
7,737,133 |
Formulations and methods of treating inflammatory bowel disease
|
| 9 |
7,691,832 |
Methods of treatment of inflammatory diseases
|
| 10 |
7,638,507 |
Compositions for treatment of inflammatory diseases
|
| 11 |
7,608,642 |
Wound and skin care compositions
|
| 12 |
7,605,150 |
Drug therapy for Celiac Sprue
|
| 13 |
7,417,037 |
Compositions and methods of treatment for inflammatory diseases
|
| 14 |
7,183,269 |
Synergistic compositions for the selective control of tumor tissue
|
| 15 |
7,098,189 |
Wound and skin care compositions
|
| 16 |
7,094,431 |
Method of healing skin wounds in mammals and a composition therefor
|
| 17 |
6,855,341 |
Anti-viral compositions and methods of making and using the anti-viral
compositions
|
| 18 |
6,800,434 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
| 19 |
6,783,767 |
Low temperature disinfectant/sterilant for medical devices and topical
applications
|
| 20 |
6,730,329 |
Zinc containing compositions for anti-viral use
|
| 21 |
6,727,235 |
Synergistic compositions for the selective control of tumor tissue
|
| 22 |
6,525,038 |
Synergistic compositions for the selective control of tumor tissue
|
| 23 |
6,475,526 |
Zinc containing compositions for anti-viral use
|
| 24 |
6,440,406 |
Attractant for monitoring and control of adult scarabs
|
| 25 |
6,395,720 |
Synergistically acting compositions for selectively combating tumor tissue
|
| 26 |
6,306,843 |
Method for producing stable acetylsalicylic acid solutions
|
| 27 |
6,232,341 |
Topical pharmaceutical compositions for healing wounds
|
| 28 |
6,074,634 |
Feeding attractant and stimulant for adult control of noctuid and/or
other lepidopteran species
|
| 29 |
5,922,785 |
Dental resins
|
| 30 |
5,919,776 |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
| 31 |
5,885,976 |
Methods useful for the treatment of neurological and mental disorders
related to deficient serotonin neurotransmission and impaired pineal
melatonin functions
|
| 32 |
5,830,884 |
Pharmaceutical products containing thermally-inhibited starches
|
| 33 |
5,691,325 |
Method for ameliorating age-related disease conditions
|
| 34 |
5,691,324 |
Methods useful for the treatment of neurological and mental disorders
related to deficient serotonin neurotransmission and impaired pineal
melatonin functions
|
| 35 |
5,650,398 |
Drug delivery enhancement via modified saponins
|
| 36 |
5,470,846 |
Treatment of neurological and mental disorders
|
| 37 |
5,443,829 |
Modified saponins isolated from Quillaja saponaria
|
| 38 |
5,336,271 |
Method for increasing the proportion of a crystalline organic compound
which remains uncrystallized in a composite particulate product and
suppressing recrystallization
|
| 39 |
5,273,965 |
Methods for enhancing drug delivery with modified saponins
|
| 40 |
5,217,965 |
Stabilized solid dosage forms of choline metal carboxymethylcellulose
salicylate compositions
|
| 41 |
5,108,991 |
Vehicle composition containing 1-substituted azacycloalkan-2-ones
|
| 42 |
4,822,604 |
Local treatment of dandruff, seborrheic dermatitis, and psoriasis
|
| 43 |
4,775,667 |
Topical analgesic anti-inflammatory composition
|
| 44 |
4,758,555 |
Method for treating convulsions and epilepsy with organic copper
compounds
|
| 45 |
4,757,060 |
Non-steroidal anti-inflammatory compositions protected against
gastrointestinal injury with a combination of certain H.sub.1 and
H.sub.2, receptor blockers
|
| 46 |
4,591,584 |
Azo-bis-salicylic acid and salt thereof, to treat inflammatory
conditions of the intestine
|
| 47 |
4,483,854 |
Systemic treatment of psoriasis using certain salicylates
|
| 48 |
4,419,363 |
Alkanolamine derivatives
|
| 49 |
4,067,974 |
Stabilized solid form choline salicylate compositions
|
| 50 |
4,059,690 |
Topical liquid or ointment
|
